Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 6Terminated 2Active not recruiting 2Suspended 1Not yet recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1CNS 1

Conditions

Recurrent Head and Neck Carcinoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Follicular 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1Glioblastoma 1Eyelid Squamous Cell Carcinoma 1Astrocytoma 1

Interventions

aldesleukin 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Magnetic Resonance Spectroscopy 1Craniotomy 1Carboplatin 1Bevacizumab 13-aminopyridine-2-carboxaldehyde thiosemicarbazone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Astrocytoma × Radiotherapy, Intensity-Modulated × Clear all
NCT06860594 2026-05-13

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

National Cancer Institute (NCI)

Phase 1 Suspended
30 enrolled
CNSLymphoid

Astrocytoma, Glioblastoma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡